Lin BioScience, Inc. (6696)
TWSE
176.00
+3.00 (+1.73%)
Closed
Oct 8, 2026
Day's Range
172.50179.50
52 wk Range
18.35207.00
Financial Statements - 6696 - Lin BioScience, Inc.
Net Income
-2.58B▼ 105.1%
EBITDA
-2.61B▼ 99.8%
Free Cash Flow
-1.44B▼ 41.2%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | - | - | - | - | - | - |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -2.85B | -1.45B | -1.09B | -445.12M | -338.27M | -196.99M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | -2.63B | -1.32B | -1.09B | -477.87M | -490.41M | -174.79M |
| Income Tax | -55.33M | -69.60M | -29.72M | -18.43M | -9.50M | -22.95M |
| Net Income | -2.58B | -1.25B | -1.06B | -459.43M | -480.90M | -151.84M |
| EPS Basic | -1.66 | -0.947 | -9.224548 | -4.339211 | -6.229617 | -2.385911 |
| EPS Diluted | -1.66 | -0.947 | -9.224548 | -4.339211 | -6.229617 | -2.385911 |
| Basic Shares Outstanding | 821.07M | 786.02M | 74.51M | 72.24M | 69.79M | 63.53M |
| Diluted Shares Outstanding | 821.07M | 786.02M | 74.51M | 72.24M | 69.79M | 63.53M |
| Ebit | -2.63B | -1.32B | -1.08B | -476.99M | -490.34M | -174.53M |
| Ebitda | -2.61B | -1.30B | -1.07B | -465.84M | -485.95M | -170.46M |
| Net Income Continuous Operations | -2.63B | -1.32B | -1.09B | -477.87M | -490.41M | -174.79M |
| Minority Interests | 1.21B | 514.44M | 373.62M | 145.91M | 46.20M | 0 |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
